Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Yumi Endo"'
Autor:
Yumi Endo, Hiroshi Sugiura, Hiroko Yamashita, Satoru Takahashi, Nobuyasu Yoshimoto, Mai Iwasa, Tomoko Asano, Tatsuya Toyama
Publikováno v:
Case Reports in Oncological Medicine, Vol 2013 (2013)
Myoepithelial carcinoma (malignant myoepithelioma) of the breast is a rare tumor, for which only a limited number of reports have been published. Most of the reports emphasized diagnosis and pathology but not biological behavior and treatment. We rep
Externí odkaz:
https://doaj.org/article/39939fbd6d974d54a4df37b552f39c53
Autor:
Hiroyuki Kato, Mayumi Nishimoto, R Nakanishi, Sayaka Nishikawa, Katsuhiro Okuda, Tatsuya Toyama, Yu Dong, Naoto Kondo, Tomoka Hisada, Yumi Endo, S. Takahashi, Yukari Hato
Publikováno v:
Cancer Research. 78:P3-08
Background: Breast cancer cells disseminate to the bone marrow and form bone metastases in a large majority of late-stage patients. Retinoic Acid-Induced 2 (RAI2) was reported as a putative suppressor of early hematogenous dissemination of tumor cell
Autor:
Masato Sone, Motoi Harada, Tomoko Hashimoto, Saori Kimura, Sungmin Kang, Eun-Woo Lee, Hiromichi Kurosu, Junji Watanabe, Yumi Endo
Publikováno v:
Journal of Molecular Structure. 1105:34-40
Solid-state 13 C nuclear magnetic resonance (NMR) measurements were performed on the hexagonal columnar and cubic phases of an acute-angle banana-shaped molecule, N(1,7)-S30. In the hexagonal columnar phase, three peaks appear at the NMR chemical shi
Autor:
Yumi Endo1 yendo424@med.nagoya-cu.ac.jp, Hiroko Yamashita2 hirokoy@huhp.hokudai.ac.jp, Satoru Takahashi3 sattak@med.nagoya-cu.ac.jp, Shinya Sato3 satopin@med.nagoya-cu.ac.jp, Nobuyasu Yoshimo1 paris@s4.dion.ne.jp, Tomoko Asano1 rinkomaneko@hotmail.co.jp, Yukari Hato1 yukarinhato@gmail.com, Yu Dong1 dongyufish@yahoo.co.jp, Yoshitaka Fujii1 yosfujii@med.nagoya-cu.ac.jp, Tatsuya Toyama1 t.toyama@med.nagoya-cu.ac.jp
Publikováno v:
BMC Cancer. 2014, Vol. 14 Issue 1, p1-20. 20p.
Autor:
Yu Dong, Hiroyuki Kato, Akiko Kato, Naoto Kondo, Tomoka Hisada, Mitsuo Terada, Tatsuya Toyama, Satoru Takahashi, Sayaka Nishikawa, Yasuaki Uemoto, Yumi Endo, Yusuke Katagiri, Tomoko Asano
Publikováno v:
Cancer Research. 80:P6-04
Background: Resistance to endocrine therapy and metastatic progression is a leading cause of death in estrogen receptor-alpha(ERα)-positive breast cancer patients. Recently, the scaffolding protein LLGL2 was reported to promote cellular proliferatio
Autor:
Yumi Endo, Yukiko Muramoto
Publikováno v:
Shinrigaku kenkyu : The Japanese journal of psychology. 87(5)
This is a micro-ethnographic study focusing on a traditional custom at Tōshi Island in Japan. When first-born sons in the island graduate from junior high school, they form a small group of neya-ko (quasi-brothers) and sleep over at neya-oyas’ (qu
Autor:
Satoru Takahashi, Tatsuya Toyama, Dong Yu, Nobuyasu Yoshimoto, Yukari Hato, Tomoko Asano, Yumi Endo, Shinya Sato, Yoshitaka Fujii
Publikováno v:
Cancer Research. 75:P4-11
Over 70% of breast cancers are estrogen receptor α (ERα)-positive, and endocrine therapy targeting estrogen action decreases mortality from breast cancer. However, their efficacy of endocrine therapy is limited by intrinsic and acquired resistance.
Autor:
Akiko, Ogiya, Kieko, Yamazaki, Rie, Horii, Tadahiko, Shien, Yoshiya, Horimoto, Norikazu, Masuda, Touko, Inao, Mitsuchika, Hosoda, Naoko, Ishida, Tomofumi, Osako, Masato, Takahashi, Yumi, Endo, Yuichiro, Miyoshi, Hiroyuki, Yasojima, Nobumoto, Tomioka, Hiroko, Yamashita
Publikováno v:
Breast cancer (Tokyo, Japan). 24(4)
Autor:
Yu Dong, Tatsuya Toyama, Yumi Endo, Tomoko Asano, Yoshitaka Fujii, Nobuyasu Yoshimoto, Yukari Hato, Satoru Takahashi, Shinya Sato
Publikováno v:
Japanese Journal of Clinical Oncology. 44:889-897
Objective Over 70% of breast cancers are estrogen receptor alpha-positive, and endocrine therapy targeting estrogen action decreases mortality from breast cancer. Recently, a novel protein kinase that regulates estrogen receptor alpha activity, lemur
Autor:
Shinya Sato, Yumi Endo, Yoshitaka Fujii, Tomoko Asano, Hiroko Yamashita, Nobuyasu Yoshimoto, Satoru Takahashi, Tatsuya Toyama, Yukari Hato, Yu Dong
Publikováno v:
Japanese Journal of Clinical Oncology. 44:619-623
OBJECTIVE Human epidermal growth factor receptor 2 (HER2) gene amplification is a major therapeutic target in breast cancer, and has been introduced as a predictive biomarker to identify patients who may benefit from therapy with anti-human epidermal